RxSight (RXST) Short-term Investments (2020 - 2026)

RxSight (RXST) has 7 years of Short-term Investments data on file, last reported at $200.3 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 0.51% year-over-year to $200.3 million; the trailing twelve-month figure through Mar 2026 stood at $200.3 million (down 0.51% YoY), and the FY2025 full-year result was $208.2 million, down 5.6% from the prior year.
• Short-term Investments for Q1 2026 stood at $200.3 million, down from $208.2 million in the prior quarter.
• Across five years, Short-term Investments topped out at $220.5 million in Q4 2024 and bottomed at $92.7 million in Q1 2024.
• The 5-year median for Short-term Investments is $142.9 million (2023), against an average of $157.7 million.
• The widest annual swing landed in 2022, when Short-term Investments soared 423.13%; it then plunged 35.14% in 2024.
• A 5-year view of Short-term Investments shows it stood at $94.0 million in 2022, then gained by 25.03% to $117.5 million in 2023, then surged by 87.69% to $220.5 million in 2024, then slipped by 5.6% to $208.2 million in 2025, then declined by 3.78% to $200.3 million in 2026.
• The last three Short-term Investments figures came in at $200.3 million (Q1 2026), $208.2 million (Q4 2025), and $197.9 million (Q3 2025), per Business Quant data.

Peer Comparison